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Intracellular bacterial, Listeria monocytogenes generates
cyclic diadenosine monophosphate (c-di-AMP) can active
interferon regulatory factor3 (IRF3) and nuclear factor
kappa-light-chain-enhancer (NF-B) and induces B cell
and macrophage secretion of IFN-b [1]. Cyclic diguanylic
acid (c-di-GMP) also acts as an important signaling mole-
cule in a variety of bacterial species infection functions.
IFN-b actives NK cells through Tyk2-STAT1 signal path-
way. Our studied showed CDNs anti-tumor effective
dependent IFNa/b receptors (IFNAR1/IFNAR2) on
the cell plasma membrane. Some study showed c-di-GMP
significantly inhibited the proliferation of human colon
cancer cells in vitro [2]. Cyclic dinucleotides (CDNs, c-di-
AMP and c-di-GMP) are sensed by STING (stimulator of
interferon genes). But CDNs were developed for prevent
and therapeutic cancers, it was a novel method. We com-
bined GM-CSF-producing tumor vaccine and TLR ago-
nists enhanced systemic anti-tumor immunity. Our
studied showed the regimen significantly inhibition mice
tumors growth in B16 melanoma and colon cancer in vivo.
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